Important regulatory notice. Retatrutide is an investigational compound currently in Phase 3 clinical trials and is not licensed for human or veterinary use in the United Kingdom by the MHRA, EMA or FDA. This page is a research-context summary of the published Phase II clinical-trial protocol design only. It is not dosing advice, not a…
